Research ArticleArticle
Bioengineered NRF2-siRNA is effective to interfere with NRF2 pathways and improve chemosensitivity of human cancer cells
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijiang Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
Drug Metabolism and Disposition November 3, 2017, dmd.117.078741; DOI: https://doi.org/10.1124/dmd.117.078741
Peng-Cheng Li
1 UC Davis School of Medicine; Wuhan University;
Mei-Juan Tu
2 UC Davis School of Medicine;
Pui Yan Ho
2 UC Davis School of Medicine;
Joseph L. Jilek
2 UC Davis School of Medicine;
Zhijiang Duan
2 UC Davis School of Medicine;
Qian-Yu Zhang
2 UC Davis School of Medicine;
Ai-Xi Yu
3 Wuhan University
Ai-Ming Yu
2 UC Davis School of Medicine;
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Bioengineered NRF2-siRNA is effective to interfere with NRF2 pathways and improve chemosensitivity of human cancer cells
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijiang Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
Drug Metabolism and Disposition November 3, 2017, dmd.117.078741; DOI: https://doi.org/10.1124/dmd.117.078741
Research ArticleArticle
Bioengineered NRF2-siRNA is effective to interfere with NRF2 pathways and improve chemosensitivity of human cancer cells
Peng-Cheng Li, Mei-Juan Tu, Pui Yan Ho, Joseph L. Jilek, Zhijiang Duan, Qian-Yu Zhang, Ai-Xi Yu and Ai-Ming Yu
Drug Metabolism and Disposition November 3, 2017, dmd.117.078741; DOI: https://doi.org/10.1124/dmd.117.078741
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement